A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial

BACKGROUND: Effective topical treatment options for patients with primary axillary hyperhidrosis (PAHH) are limited. A phase I trial showed promising results regarding the efficacy and safety of a topical cream containing glycopyrronium bromide (GPB). OBJECTIVES: To assess the efficacy, safety and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abels, C., Soeberdt, M., Kilic, A., Reich, H., Knie, U., Jourdan, C., Schramm, K., Heimstaedt‐Muskett, S., Masur, C., Szeimies, R.‐M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451866/
https://www.ncbi.nlm.nih.gov/pubmed/33445205
http://dx.doi.org/10.1111/bjd.19810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451866/
https://www.ncbi.nlm.nih.gov/pubmed/33445205
http://dx.doi.org/10.1111/bjd.19810

Ejemplares similares